Arrowhead Pharmaceuticals has surged over 240% in six months, driven by major partnerships and its RNAi drug pipeline. Recent catalysts include a $200M Novartis deal, $300M from Sarepta, and the first ...
Add Yahoo as a preferred source to see more of our stories on Google. Later this year, when the Hallmark Christmas movie about the Kansas City Chiefs debuts, the world will get to see just how ...
The Kansas City Chiefs made a key decision about the future of Arrowhead Stadium on August 5, announcing that they would be returning to a previous naming convention for their home turf. Now, the ...
It turns out the biggest reason Helldivers players were not playing the game were other Helldivers players. Yesterday, we had reported that Helldivers 2 was suffering from success, with Arrowhead Game ...
PARKVILLE, Mo. — KSHB 41 reporter Tod Palmer covers sports business and eastern Jackson County. Share your story idea with Tod. Kansas City Chiefs fans relish the fact that they’ve helped make GEHA ...
Arrowhead Pharmaceuticals (ARWR) has surged over 240% in 2025, driven by major partnership deals and its first commercial approval for Redemplo. ARWR's valuation is buoyed by $200M upfront from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results